Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer

被引：0

作者：

Leyvraz, S. ^{[1
]}

Hong, D. S. ^{[2
]}

Shen, L. ^{[3
]}

van Tilburg, C. M. ^{[4
,5
]}

Tan, D. S. W. ^{[6
]}

Kummar, S. ^{[7
]}

Lin, J. J. ^{[8
,9
]}

Doz, F. ^{[10
,11
]}

McDermott, R. ^{[12
,13
]}

Albert, C. M. ^{[14
,15
]}

Berlin, J. ^{[16
]}

Bielack, S. ^{[17
]}

Lassen, U. N. ^{[18
]}

Tahara, M. ^{[19
]}

Norenberg, R. ^{[20
]}

Shurshalina, A. ^{[21
]}

Fellous, M. ^{[22
]}

Nogai, H. ^{[22
]}

Xu, R. ^{[23
]}

Laetsch, T. W. ^{[24
]}

Drilon, A. ^{[25
,26
]}

机构：

[1] Charite Comprehens Canc Ctr, Berlin, Germany

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Peking Univ, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Minist Educ Beijing,Canc Hosp & Inst, Beijing, Peoples R China

[4] Heidelberg Univ Hosp, Hopp Childrens Canc Ctr Heidelberg KiTZ, Heidelberg, Germany

[5] German Canc Res Ctr, Heidelberg, Germany

[6] Natl Canc Ctr Singapore, Singapore, Singapore

[7] OHSU, Knight Canc Inst, Portland, OR USA

[8] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA

[9] Harvard Med Sch, Boston, MA 02115 USA

[10] Inst Curie, Paris, France

[11] Univ Paris, Paris, France

[12] St Vincents Univ Hosp, Dublin, Ireland

[13] Canc Trials Ireland, Dublin, Ireland

[14] Seattle Childrens Hosp, Seattle, WA USA

[15] Univ Washington, Sch Med, Seattle, WA USA

[16] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[17] Klinikum Stuttgart Olgahosp, Stuttgart, Germany

[18] Rigshosp, Dept Oncol, Copenhagen, Denmark

[19] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[20] Chrestos Concept GmbH & Co KG, Essen, Germany

[21] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[22] Bayer HealthCare Pharmaceut Inc, Basel, Switzerland

[23] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China

[24] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[25] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[26] Weill Cornell Med Coll, New York, NY USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2021年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V101

引用

页码：13 / 13

页数：1

共 50 条

[1] Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.
Hong, David S.
Shen, Lin
van Tilburg, Cornelis Martinus
Tan, Daniel Shao-Weng
Kummar, Shivaani
Lin, Jessica Jiyeong
Doz, Francois P.
McDermott, Raymond S.
Albert, Catherine M.
Berlin, Jordan
Bielack, Stefan S.
Lassen, Ulrik Niels
Tahara, Makoto
Norenberg, Ricarda
Shurshalina, Anna
Fellous, Marc Mardoche
Nogai, Hendrik
Xu, Rui-hua
Laetsch, Theodore Willis
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[2] Long-term efficacy and safety of larotrectinib in patients with TRK fusion lung cancer.
Drilon, Alexander E.
Kummar, Shivaani
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Moreno, Victor
Leyvraz, Serge
Dubashi, Biswajit
Haresh, K. P.
Burcoveanu, Domnita-Ileana
Neu, Natascha
Mussi, Chiara E.
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[3] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An expanded dataset
Garralda, E.
Hong, D.
Xu, R.
Deeken, J.
Italiano, A.
Liu, T.
Ferrandiz, A.
Patel, J.
Lee, D.
Chung, H.
Kinoshita, I.
Berlin, J.
Andre, T.
Oh, D.
Leyvraz, S.
Miguel, M.
Liu, Y.
Norenberg, R.
Fellous, M.
Mussi, C.
Drilon, A.
Shen, L.
ANNALS OF ONCOLOGY, 2022, 33 : S370 - S370
[4] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Lin, Jessica Jiyeong
Tan, Daniel Shao-Weng
Kummar, Shivaani
Patel, Jyoti D.
Cermignani, Luciano
Dai, Ming-Shen
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Rosen, Lee S.
Saada-Bouzid, Esma
Solomon, Benjamin Maurice
Xu, Rui-Hua
Yachnin, Jeffrey
Norenberg, Ricarda
Burcoveanu, Domnita-Ileana
Mussi, Chiara E.
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[5] Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion lung cancer
Rieke, D. T.
Lin, Iyeong J.
Tan, D. S.
Kummar, S.
Patel, J. D.
Cermignani, L.
Dai, M. -S.
Lassen, U. N.
Leyvraz, S.
Liu, Y.
Moreno, V.
Rosen, L.
Saada-Bouzid, E.
Solomon, B.
Xu, R. -H.
Yachnin, J.
Norenberg, R.
Burcoveanu, D. -I.
Mussi, C. E.
Shen, L.
Drilon, A.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 9 - 10
[6] Long-term efficacy and safety of larotrectinib in patients with TRK fusion-positive lung cancer.
Lin, Jessica Jiyeong
Kummar, Shivaani
Tan, Daniel Shao-Weng
Lassen, Ulrik Niels
Leyvraz, Serge
Liu, Yongmei
Moreno, Victor
Patel, Jyoti D.
Rosen, Lee S.
Solomon, Benjamin Maurice
Norenberg, Ricarda
Dima, Laura
Brega, Nicoletta
Shen, Lin
Drilon, Alexander E.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[7] Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion Cancer
Rieke, D. T.
Hong, D. S.
Drilon, A.
Tan, D. S.
Lin, J.
Kummar, S.
McDermott, R.
Berlin, J.
Italiano, A.
Lassen, U. N.
Leyvraz, S.
Tahara, M.
Norenberg, R.
Burcoveanu, D. -I.
Brega, N.
Shen, L.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 142 - 143
[8] Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer
McDermott, R.
van Tilburg, C. M.
Farago, A. F.
Kummar, S.
Tan, D. S. W.
Albert, C. M.
Berlin, J.
Lassen, U. N.
Doz, F.
Geoerger, B.
Mascarenhas, L.
Federman, N.
Reeves, J. A.
Dima, L.
Brega, N.
De La Cuesta, E.
Laetsch, T. W.
Hong, D. S.
Drilon, A.
ANNALS OF ONCOLOGY, 2020, 31 : S1101 - S1102
[9] Efficacy and safety of larotrectinib in patients with TRK fusion breast cancer
Rosen, Ezra Y.
Italiano, Antoine
Juric, Dejan
Reeves, John A.
Dima, Laura
Brega, Nicoletta
Drilon, Alexander
CANCER RESEARCH, 2021, 81 (04)
[10] Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
Qi, Changsong
Shen, Lin
Andre, Thierry
Chung, Hyun Cheol
Cannon, Timothy L.
Garralda, Elena
Italiano, Antoine
Rieke, Damian T.
Liu, Tianshu
Burcoveanu, Domnita-Ileana
Neu, Natascha
Mussi, Chiara E.
Xu, Rui-Hua
Hong, David S.
Drilon, Alexander
Berlin, Jordan
EUROPEAN JOURNAL OF CANCER, 2025, 220

← 1 2 3 4 5 →